Foghorn Therapeutics
FHTX4.7400.00% ( 0.000 )
Foghorn Therapeutics (FHTX)
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined de...
- Open
- 4.740
- High
- 4.830
- Low
- 4.605
- Prev. Close
- 4.740
- Volume
- 173.42K
- Turnover
- 820.41K
- Avg Price
- 4.731
- Bid/Ask Ratio
- --
- Amplitude
- 4.75%
- 52wk High
- 6.950
- Volume Ratio
- 0.89
- Turnover Ratio
- 0.63%
Foghorn Therapeutics Analyst Rating
View MoreForecast & Rating
Jul 20, 2026Price forecast
$11.44141.44%
Forecast & RatingStrong buy
10analysts
- Strong buy90.00%
- Buy10.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Global Report · Jul 9 at 09:02 PM
Beyond Big Tech: 10 Under-the-Radar US Stocks Making Moves This Week
- Global Report · Jul 9 at 05:03 AM
Capital Rotates into Niche Tech and Healthcare Restructurings
- PUBT · Jun 23 at 03:51 PM
Firy shareholders elect directors at annual meeting
- StockTitan · Jun 4 at 10:00 PM
Foghorn Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026 | FHTX Stock News
- benzinga_article · May 15 at 04:06 PM
12 Health Care Stocks Moving In Friday's After-Market Session
- Tip Ranks · May 8 at 06:03 AM
Foghorn Therapeutics (FHTX) Receives a Buy from H.C. Wainwright
